Pharmaceuticals

Radiotheranostics Market Size, Share & Trends Analysis Report By Radioisotope, By Source (Nuclear Reactors, Cyclotrons), By Approach, By Application(Oncology, Non-Oncology), By End-User, By Region, And Segment Forecasts, 2025-2034

Global Radiotheranostics Market Size is valued at USD 2.54 billion in 2024 and is predicted to reach USD 8.73 billion by the year 2034 at an 6.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The global radio theranostics market is expected to be driven by the expanding role of nuclear medicine in managing various chronic diseases and the rising demand for precision medicine. An increasi...

Report ID: 1499  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 185

RAS-Targeting Drugs for Precision Oncology Market Size, Share & Trends Analysis Distribution by Drug Type (Small Molecule Inhibitors, Biologics, RNA-Based Therapies, Combination Therapies), Target Mutation (KRAS G12C, KRAS G12D, KRAS G12V, G12R, G12S, G12A, HRAS and NRAS, Pan-RAS), Indication (Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC), Other Cancers (e.g., HNSCC, melanoma, hematologic)), Route of Administration (Oral, Intravenous, Other Routes) and Segment Forecasts, 2025-2034

Global RAS-Targeting Drugs for Precision Oncology Market Size is predicted to grow with a 11.9% CAGR during the forecast period for 2025-2034. The RAS-targeting medicines in precision oncology is a fast-developing area dedicated to treatments that block RAS proteins—indispensable molecular promoters in aggressive forms of cancer such as lung, colorectal, and pancreatic cancer. RAS gene mutations (KRAS, NRAS, and HRAS) are some of the ...

Report ID: 3074  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 170

Mobile Healthcare Clinic Market Size, Share & Trends Analysis Report By Service Type (Maternal Health, Emergency Care, Geriatric Care, Dental Care, OPD, Others), By Vehicle Type, By Design Layout, By Region, And By Segment Forecasts, 2025-2034

Mobile Healthcare Clinic Market Size is valued at USD 2.11 Bn in 2024 and is predicted to reach USD 5.82 Bn by the year 2034 at a 10.8% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Increasing smartphone adoption and mobile internet access are driving the mobile clinic healthcare market. Government and healthcare system investments in mHealth tech are driving the mobile healt...

Report ID: 2027  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Particle Therapy Market Size, Share & Trends Analysis Report By Type (Proton Type, Heavy Ion Therapy), By Product & Service (Cyclotrons, Synchrotrons, Synchrocyclotrons), By System, By Cancer Type, By Application, By Region, And By Segment Forecasts, 2025-2034

Particle Therapy Market Size is valued at USD 753.10 Mn in 2024 and is predicted to reach USD 1796.73 Mn by the year 2034 at a 9.3% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Particle therapy is gaining traction as a promising treatment modality for various types of cancers due to its precision and reduced side effects. Collaborations and partnerships among key industry players and re...

Report ID: 2040  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Digital Pharmaceutical Supply Chain Management Market Size, Share & Trends Analysis Report by Product (Software, Hardware), By Mode Of Delivery (Cloud-based, Web-based, and On -premises), By Software Modules (Software Modules Planning & Analytics, Procurement, Manufacturing, Logistics, and Inventory management) By Region, And By Segment Forecasts, 2025-2034

Digital Pharmaceutical Supply Chain Management Market Size is valued at USD 1163.34 million in 2024 and is predicted to reach USD 2534.55 million by the year 2034 at an 8.2% CAGR during the forecast period for 2025-2034. Key Insights: The increased utilization of process automation in pharmaceutical supply chain management, the advent of cloud-based solutions, and increased need for operational cost reductions in pharma sector are all likel...

Report ID: 1911  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Quinapril Hydrochloride Market Size, Share & Trends Analysis Report By Formulation Type (Tablet, Injection), By Application (Hypertension, Heart Failure, Cardiovascular Diseases, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)), by Region, And by Segment Forecasts, 2025-2034.

Global Quinapril Hydrochloride Market Size is valued at USD 1.3 Bn in 2024 and is predicted to reach USD 2.2 Bn by the year 2034 at a 5.9% CAGR during the forecast period for 2025-2034. The prescription drug quinapril hydrochloride belongs to the pharmacological class of angiotensin-converting enzyme (ACE) inhibitors. It is primarily used to treat heart failure and hypertension by relaxing blood vessels, which makes blood flow easier and reduces...

Report ID: 3066  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Chronic Rhinosinusitis with Nasal Polyps Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatments (Corticosteroids, Antibiotics, Biologic Drugs, Antihistamines, Leukotriene Modifiers), Surgical Interventions, Others), By Route of Administration (Oral, Nasal, Injectable), By Distribution (Direct Sales, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialized Clinics and ENT Practices, Ambulatory Surgical Centers)), by Region, And by Segment Forecasts, 2025-2034.

Chronic Rhinosinusitis with Nasal Polyps Market Size is valued at USD 1.8 Bn in 2024 and is predicted to reach USD 3.4 Bn by the year 2034 at a 6.6% CAGR during the forecast period for 2025-2034. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a disorder marked by benign inflammatory lesions called nasal polyps and ongoing sinus inflammation. Many symptoms, including facial pressure or pain, nasal congestion, hyposmia or anosmia (a dimini...

Report ID: 3069  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Radioligand Therapy Market Size, Share & Trends Analysis Report By Target(Prostate-Specific Membrane Antigen, Cancerous bone lesions, Somatostatin receptor type 2 (SSTR2)), By Indications, By Products, By Emission By Region, And By Segment Forecasts, 2025-2034

The Radioligand Therapy Market Size is valued at USD 2.31 Billion in 2024 and is predicted to reach USD 8.33 Billion by the year 2031 at a 12.1% CAGR during the forecast period for 2025-2034.   Radioligand therapy (RLT) is a cancer treatment strategy that uses targeted medicines. Radioactive isotopes, especially beta-emitters like lutetium-177, are used to identify ligands. It can yield a high rate of long-term tumor remission and sta...

Report ID: 1281  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Orodispersible Tablets Market Size, Share & Trends Analysis Report by Drug Class (Analgesics, Antiemetics, Antipsychotics, Anti-inflammatory Drugs, Sedatives/Hypnotics, Antihypertensives, Others), By Disease Indication (Central Nervous System Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Respiratory Disorders, Allergy and Asthma, Others), By Distribution Channel, By Age Group, By End User, By Technology , Region And Segment Forecasts, 2023-2031

Orodispersible Tablets Market Size is valued at 10.71 billion in 2024 and is predicted to reach 29.47 billion by the year 2034 at a 10.8% CAGR during the forecast period for 2025-2034. The orodispersible tablets market, known as orally disintegrating tablets (ODTs), has acquired substantial interest and appeal in the pharmaceutical sector. These tablets are designed to dissolve fast in the mouth without needing water or swallowing, making them a...

Report ID: 1916  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180

Live Cell Encapsulation Market Size, Share & Trends Analysis Report, By Therapeutic Area (Eye Disorders, Metabolic Disorders, Neurological Disorders, and Oncological Disorders), By Target Disease Indication, By Type of Encapsulation Material, By Region, Forecasts, 2025-2034

Live Cell Encapsulation Market Size Was valued at USD 174.2 Mn in 2024 and is predicted to reach USD 305.5 Mn by 2034 at a 5.9% CAGR during the forecast period for 2025-2034. The technique of encasing living cells in a protective matrix or structure is known as "live cell encapsulation."  This makes it possible to transplant the cells into the host body without disrupting homeostasis or triggering an immunological reaction. Additionally, ...

Report ID: 3059  |  

Delivery: Immediate  |  

Published: June 2025   |  

No. of Pages: 180